PRESS RELEASE published on 04/18/2023 at 13:00, 1 year 11 months ago CureVac to Report Fourth Quarter and Full-Year 2022 Financial Results and Business Updates on April 25, 2023
PRESS RELEASE published on 03/28/2023 at 22:05, 2 years ago CureVac Announces Voting Results of Extraordinary General Meeting
PRESS RELEASE published on 02/10/2023 at 22:05, 2 years 1 month ago CureVac Announces Closing of $250 million Follow-on Public Offering of Common Shares
PRESS RELEASE published on 02/08/2023 at 02:03, 2 years 1 month ago CureVac Announces Pricing of Upsized Public Offering of Common Shares
PRESS RELEASE published on 02/06/2023 at 22:05, 2 years 2 months ago CureVac Announces Proposed Public Offering of Common Shares
PRESS RELEASE published on 02/01/2023 at 13:00, 2 years 2 months ago CureVac Welcomes Myriam Mendila as New Chief Development Officer
PRESS RELEASE published on 01/31/2023 at 14:12, 2 years 2 months ago CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis®
PRESS RELEASE published on 01/30/2023 at 13:00, 2 years 2 months ago CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs
PRESS RELEASE published on 01/09/2023 at 13:00, 2 years 2 months ago CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
PRESS RELEASE published on 01/06/2023 at 13:00, 2 years 3 months ago CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs
Published on 04/07/2025 at 00:05, 7 hours 20 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 22 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 25 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 13 hours 4 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 16 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 24 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 24 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 13 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
